Pharmacist developed & tested ENDOMAL-SV1
Injection

ENDOMAL-SV1

Endomal-SV1 Injection contains α-β Arteether 150 mg/ml, an artemisinin derivative with antimalarial activity. It is used for the management of malaria, particularly when injectable antimalarial therapy is clinically indicated.

α-β Arteether 150mg/ml
Anti-malarial
Injection
ENQUIRE NOW

Medicine Information

Product information:

Endomal-SV1 Injection contains α-β Arteether 150 mg/ml, an artemisinin derivative with antimalarial activity. It is used for the management of malaria, particularly when injectable antimalarial therapy is clinically indicated.

Arteether acts rapidly against malaria parasites and helps reduce the parasite burden in the bloodstream.

Key Benefits:

  • Arteether acts quickly against Plasmodium falciparum ensuring fast reduction of parasite load in severe malaria.
  • Targets blood schizonts and interrupts parasite multiplication cycle.
  • Recommended in complicated or cerebral malaria where oral therapy is not feasible.
  • Rapid fever reduction, prevention of severe complications, and lower mortality.
  • Safe parenteral administration with good tolerability profile.
  • Part of artemisinin‑based combination therapies (ACTs) recommended globally for malaria management.
  • Widely used in hospital settings for critically ill malaria patients.

Directions for use:

Endomal-SV1 Injection should be administered only by a qualified healthcare professional through the appropriate parenteral route. The dose, frequency and duration of treatment should be determined by the treating physician based on the patient's body weight, age, severity of malaria and clinical condition. Do not self-administer.

Storage and Safety Information:

  • Store in a cool, dry place, protected from direct sunlight and excessive heat.
  • Keep out of reach of children.
  • Use only under the supervision of a qualified healthcare professional.
  • Do not self-administer.
  • Inform your healthcare professional about any known allergies, existing medical conditions and medicines being taken.
  • Patients receiving injectable antimalarial treatment may require appropriate clinical monitoring.
  • Seek immediate medical attention if malaria symptoms worsen, persist, or recur.
  • Do not use if the ampoule, vial or packaging is damaged or if the preparation appears unsuitable for use.

TAKE THE NEXT STEP

Partner with us

Whether you're a distributor, wholesaler, healthcare professional, or business partner, we're ready to grow together.

ENQUIRE NOW BECOME A DISTRIBUTOR